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PROTEIN PROFILES OF IN VITRO CULTURED 
PREIMPLANTATION MOUSE EMBRYOS 
Darrin Lee 
Morehead Stat 
Director of Thesis: 
Preimplantation mouse embryos (PIEs) were 
investigated in vitro to determine the influence of 
17-~-estradiol and tamoxifen on protein profiles. 
Stage-specific mouse embryos (2-cell, 4-cell, and 8-cell) 
were cultured for 8 hours in Whitten's Modified Medium 
supplemented with 17-~-estradiol and/or tamoxifen. Upon 
completion of the culturing process, PIEs were analyzed 
for embryogenetic progression. Following viability 
studies, PIEs were exposed to electrophoresis in two 
dimensions to obtain protein profiles for observational 
comparative analysis. Resultant data show that 
enhancement of protein synthesis will not result from 
exogenous supplements of 17-~-Estradiol in 2-cell, 4-cell 
and 8-cell PIEs. Viability and electrophoretic studies 
demonstrate that 4-cell and 8-cell PIEs are estrogen 
dependent and that endogenous estrogen production occurs 
in 4-cell and 8-cell PIEs. Tamoxifen is shown to be an 
effective antiestrogenic agent. Evidence obtained 
ii 
support the concept of embryonic genome initation at the 
late.2-cell PIE stage. 
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CHAPTER I 
INTRODUCTION 
An understanding of the. concepts related to early 
mammalian embryology has been the focus of study for 
developmental biologists for more than a century. Within 
the last forty years, research efforts detailing the 
mechanisti9 theories of mammalian development have 
resulted in the evolution of modern technologies.used by 
today's investigators (Johnson, 1977). Acceptance of 
molecular approaches to scientific inquiry has recently 
generated significant knowledge concerning embryological 
events following fertilization. Laboratory studies, 
using the rodent model (mostly mice), have yielded data 
important to the understanding of the timing of 
developmental events, the potency of the preimplantation 
embryo, and the fates of cells during early 
embryogenesis. 
Advances in experimental molecular research were 
delayed until the late 1950's as a result of insufficient 
biotechnical capabilities (Slack, 1983). Mammalian 
studies were particularly suppressed, because direct 
observations of preimplantation embryos were not possible 
1 
in viviparous mammals. The study of developmental events 
for mammals required the isolation of preimplantation 
embryos, and the establishment of tissue culture 
techniques essential to the survival of the developing 
embryo. Tissue culture problems that had to be resolved 
were: (1) the maximization of embryo yield and 
developmental uniformity through in vitro culturing 
(Gates, 1971); (2) the development of manipulation 
techniques for handling living embryos (Bedford, 1971); 
and (3) the development of microanalytical techniques 
applicable to the relatively small volume of experimental 
materials (Johnson, 1977). 
Efforts to maximize embryo yield and developmental 
uniformity have been numerous. Initial problems 
associated with embryo yield were centered on super-
ovulation, particularly in the mouse model (Edwards and 
Gates, 1959; Gates, 1971). Chang (1959) and Whittingham 
(1968) successfully identified those conditions essential 
to the in vitro culturing of unfertilized ova. The 
results of these studies allowed for the successful 
maintenance of viable ova, and the subsequent in vitro 
fertilization. Culturing procedures for mouse 
preimplantation embryos were developed by Brinster 
(1968), and Biggers, et al. (1971). 
2 
·Maintenance of preimplantation embryos, through the 
culturing process, required the development of specific 
manipulation skills to ensure embryo survival. Apparatus 
essential for the transfer of embryos from recovery 
through the early cleavage stages, while in the culture 
medium, included a variety of micromanipulating tools 
(Tarkowski, 1961; Mintz, 1962). The development of a 
new generation of laboratory equipment, such as micro-
pipetors and microscopes, have enhanced the manipulation 
of viable embryos. 
Advances in microanalytical techniques in cellular 
and molecular biology, such as electrophoresis, have made 
possible the evaluation of small volumes of experimental 
materials. Application of microanalytical techniques, 
with sufficient sensitivity for the detection of specific 
proteins and RNA synthesis, has provided researchers the 
ability to determine the macromolecular composition of 
embryonic tissues (Bolton, et al., 1984; Howlett and 
Bolton, 1985). The sensitivity of these techniques 
allows for the identification of specific ions in 
preimplantation embryos (PIEs) (Kaye, 1986). Data 
obtained through microanalytical investigations provide 
deve~opmental biologists a basis for better understanding 
the events in early embryonic development based on 
dynamic molecular interactions. 
3 
superovulation 
Laboratory research using superovulation techniques 
to collect fertilized mouse ova was first reported by 
Fowler and Edwards (1957). In this study, female mice 
were given intraperitoneal injections of two gonad-
otropins, pregnant mares' serum gonadotropin (PMSG) 
followed by human chorionic gonadotropin (hCG). 
Gonadotropin dosage varied from 2-10 international units, 
as reported by different researchers. Injections of 
gonadotropins stimulated mice to superovulate (Edwards 
and Gates, 1959), thereby, producing approximately three 
times as many ova as are produced through spontaneous 
ovulation (Gates, 1971). Hormone injections, 
administered 44-48 hours apart were shown to regulate the 
time of ovulation and allow the collection of PIEs at 
specific stages of embryological development (Edwards and 
Gates, 1959). Thus, 2-cell PIEs were collected 45 hours 
post-hCG injection (Brinster, 1965a), 4-cell PIEs were 
collected 54 hours post-hCG injection (Brinster, 1967), 
and a-cell PIEs were collected 64 hours post-hCG 
injection (Warner and Tollefson, 1978). 
The selection of the mouse strain for superovulation 
has been reported as being significant, because various 
, 
strains produce different numbers of ova when hormone-
stimulated (McLaren, 1967). Gates and Runner (1957) 
4 
reported that outbred mouse strains generated greater 
numbers of viable ova through superovulation than did 
inbred mouse strains, because outbred strains have a more 
vigorous reproductive capacity. In addition, Gates 
(1971) demonstrated that prepuberal female mice (three 
weeks of age) produced the highest yield of ova when 
hormone-stimulated. This increase in superovulation 
activity resulted from a wave of follicle maturation in 
prepuberal mice. 
Controlled lighting conditions were shown to be 
essential to the collection of PIEs following hormone 
stimulation (Whitten and Dagg, 1961). A photoperiod 
utilizing a typical light regime, between 12 and 14 hours 
duration, resulted in maximum PIE recovery. Maintenance 
of the mice under a controlled photoperiod was required 
to accurately time the occurrence of ovulation (Gates, 
1971). Under natural conditions, the surge of 
luteinizing hormone (LH) release correlates with the 
daily light/dark photoperiod and, subsequently, the 
ovulation of mature Graafian follicles (Schultz, 1986). 
Research has shown that the time interval between peak LH 
release and ovulation to be approximately 9 hours (Gates, 
1969) • 
Pregnant mares' serum gonadotropin treated mice 
release LH 11-16 hours after the second midpoint 
5 
(12:00 a.m.) of the dark period (Gates, 1969), about 
47 - 52 hours after injection (Figure 1). PMSG contains 
follicle stimulating hormone activity (FSH), which 
induces preovulatory maturation of ovarian follicles. 
The PMSG injection assured the development of mature 
Graafian follicles preceding LH stimulation (Schultz, 
1986). To regulate the time of ovulation, experimental 
animals were injected with hCG at 45 hours post-PMSG 
injection (Fowler and Edwards, 1957; Kendall, 1979). 
Human Chorionic Gonadotropin contains ovulatory hormone 
LH-like activity, and Edwards and Gates (1959) reported 
that o~ulation by exogenous LH induction required a time 
lapse of 12 hours. Whittingham (1967), working with a 
random bred strain of Swiss mice, reported that ovulation 
occurred 10.5 - 12.5 hours post-hCG injection. 
Consequently, hCG injection must be administered 3 hours 
prior to endogenous activation (Gates, 1971). 
Embryogenesis 
Fertilized ova undergo a series of cleavage 
divisions, cell division without growth, that transform 
the single-celled zygote into a multicellular blastocyst 
(Figure 2). These preimplantation divisions begin 
approximately 24 hours after fertilization, with 
subsequent divisions occurring about every 12 hours. At 
6 
5 IU PMSG~ 
Female Mouse 
12 hrs 
12 a.m. 
24 hrs 
12 a.m. 
9 hrs 
5 IU hCG~ 
Female Mouse 
Ovulation 
(12 p.m.) 
(First Midpoint) 
(Second Midpoint) 
11-16 hrs later LH 
release begins 
(9a.m.). 
to regulate ovulation 
time hCG was injected 3 
hrs prior to approximate 
LH peak 
(9 p.m.) 
Figure 1. Time intervals and considerations for hormone 
induced superovulation. 
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Oviduct 
Uterus 
Ovulation 
and 
Fertilization 
Meiosis II 
1-Cell. stage 
(Day 1) 
2-Cell Stage 
(Day 2) 
4-Cell Stage 
8-Cell Stage 
(Day 3) 
8-Cell Stage 
(Compaction) 
Figure 2. Diagrammatic outline of mouse early 
embryogene_sis (Schultz, 1986). 
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the a-cell stage, approximately 60 hours after 
fertilization, the embryo assumes a spherical shape 
through morphological reorganization; through the 
process of compaction (Johnson and Maro, 1986). The 
molecular events of compaction are dependent upon sterol 
synthesis, glycosylation of membrane proteins, and 
organization of a distinct network of microfilaments 
(Brachet and Alexandre, 1986). The process of compaction 
continues until the embryo reaches the 32-cell stage, 
when the fluid-filled blastocoel first appears (Slack, 
1983)'. During compaction, blastomeres flatten against 
each other to maximize intercellular contacts. Contact 
establishes both tight and gap junctional communications, 
and results in the disappearance of interblastomere 
furrows. As the compaction process continues, the 
cellular components of each blastomere undergo a 
rearrangement that transforms the cell pattern from a 
non-polarized to a radially polarized pattern (Schultz, 
1986). The tight junctions formed during compaction fix 
the positions of the blastomeres preventing blastomere 
movement. Polarization of the blastomeres establishes an 
inside-outside orientation, which is maintained as 
cleavage continues. The overall process of compaction is 
ca2+ dependent (Slack, 1983.; Yamamura and Spindle, 1988). 
9 
Following compaction, continued cleavage activity 
transforms the embryo into a blastocyst as it enters the 
uterine cavity. The blastocyst is composed of two 
distinct committed tissues, an outer band of 
trophectodermal cells surrounding a small group of inner 
cell mass cells that are positioned at one end of the 
blastocoel. Tarkowski and Wroblewska (1967) demonstrated 
that different environmental conditions, to which 
blastomeres were exposed, played a decisive role in the 
differentiation of the trophectoderm and the inner cell 
mass. This hypothesis, known as the inside-outside or 
epigenetic hypothesis, suggests that blastomeres remain 
totipotent through the random polarization process of the 
morula (Pedersen, 1986). studies using the inner and 
outer positioned blastomeres of 16- and 32-cell embryos 
have supported this cell potency concept (Spindle, 1978; 
Rossant and Vijh, 1980; Ziomek, et al., 1982). 
Preimplantation Culturing 
The initial problem, to be resolved for the study of 
mammalian embryonic development, was the advancement of 
suitable in vitro culturing techniques (Biggers, et al., 
1971). The principle mammal used in research involving 
culturing techniques has been various strains of 
10 
laboratory mice (Brinster, 1969a and b; Whittingham, 
1971; Whitten, 1971; Biggers, et al., 1971). 
The initial report of in vitro observations of mouse 
embryos was made by Hammond (1949). In his report, 
Hammond stated that successful culturing of mouse embryos 
depended on the age of the embryo being cultured; 
attempts to culture 2-cell embryos were not successful, 
but 8-cell embryos were cultured to the blastocyst stage. 
The culture medium developed by Hammond was physiological 
saline, supplemented with hen egg whites and yolk. 
Whitten (1956a) modified the culture medium 
developed by Hammond by substituting Krebs-Ringer 
bicarbonate solution, as the physiological saline, in an 
attempt to control the pH of the medium (Table 1). Other 
additions to the culture medium were glucose, penicillin, 
and streptomycin. Initially, Whitten maintained the use 
of egg whites in his medium, but discontinued the use of 
egg yolk. Through experimentation, Whitten determined 
that crystalline bovine serum albumin was a beneficial 
substitution for the egg whites. Further, Whitten gassed 
the medium with 5% co2 in air to establish a pH of 7.4. 
Utilizing this medium, Whitten successfully cultured 
8-cell mouse PIEs to the blastocyst stage. 
By 1957, researchers had been successful in their 
efforts to culture a-cell PIEs through the blastocyst 
11 
Table 1. Evolution of media based on Krebs-Ringer bicarbonate for mouse 
preimplantation culture. 
Modified 
Whitten Brinster Whitten M16 BWW Whitten BMOC-2 
1956 1957 1965 1968 1971 1971 1971 1971 1977 1983 
NaCl X X X X X X X X X X 
KCl X X X X X X X X X X 
KH2Po4 X X X X X X X X X X 
NaHC03 X X X X X X X X X X 
Cacl2 X X X X X X 
MgS04 X X X X X X X X X X 
Ca Lactate X X X X 
Na Lactate X X X X X X X X 
Na Pyruvate X X X X X X X X 
Glucose X X X X X X X X X 
BSA X X X X X X X X X X 
Penicillin X X X X X X X X X X 
Streptomycin X X X X X X X X X X 
EDTA X X 
I-' 
.., 
stage. Attempts to culture 2-cell and 4-cell PIEs had 
failed (Whitten, 1956a). To address this problem, 
Whitten altered the Krebs-Ringer bicarbonate solution by 
substituting calcium lactate (a non-deliquescent 
substance) for calcium chloride (a very deliquescent 
substance). Using the new Whitten's Medium, Whitten 
(1957a) successfully cultured 2-cell PIEs to the 
blastocyst stage (Table 1). Other modifications in 
Whitten's Medium have been made by different researchers, 
as a result of the success in culturing 2-cell PIEs 
(Biggers, 1987). 
In an effort to generate an enhanced Whitten's 
Medium, Brinster (1965a,b, and c) conducted a series of 
culture experiments using 2-cell PIEs. Initially, 
Brinster (1965b) studied concentration response curves to 
identify the optimum osmolarity required to support 
embryonic development. The study resulted in changes in 
the medium involving the addition of sodium lactate, the 
removal of glucose, and a return to the original Krebs-
Ringer bicarbonate solution (with calcium chloride). 
Whitten (1957a) had reported that metabolic 
intermediates might be beneficial in culturing PIEs. 
Considering this possibility, Brinster (1965c) 
investigated the role of intermediates of the Embden-
Meyerhoff pathway and the citric acid cycle at carrying 
13 
concentrations. He determined that pyruvate, phosphoenol 
pyruvate, and oxaloacetate could be substituted for 
lactate to enhance the culture of 2-cell PIEs into the 
blastocyst stage. 
Following his work on metabolic intermediates, 
Brin~ter (1965b) experimentally determined that lactate 
and pyruvate had a joint effect on development. 
Brinster's study demonstrated that low concentrations of 
pyruvate enhanced the developmental response of PIEs to 
lactate. Due to the succession of modifications in 
Whitten's Medium, as reported by Brinster (1965a, b, and 
c), the "new" medium was referred to as Brinster's Medium 
(Table 1). Two-cell PIEs cultured in Brinster's Medium 
would develop to the blastocyst stage with an enhanced 
rate of viability, when compared to viability using 
Whitten's original medium. Blastocysts transferred to 
recipient female mice developed into normal adults. 
Brinster's Medium was further modified when it was 
noted that the availability of three carbon sources 
(pyruvate, lactate and glucose) within the medium were 
advantageous to embryonic development (Biggers and 
Brinster, 1965),· The addition of the three energy 
sources, at different concentration levels, resulted in 
the development of numerous modifications of Brinster's 
Medium (Table 1): (1) a modified Brinster's Medium 
14 
(Brinster, 1971); (2) a new Whitten's Medium (Whitten, 
1971); (3) M16 Medium (Whittingham, 1971); (4) BWW 
Medium (Biggers, et al., 1971); and (5) BMOC-2 Medium 
(Ebert and Brinster, 1983). 
Various researchers had noted that the successful 
culturing of one-cell embryos was dependent upon the 
mouse strain used in PIE studies; some one-cell embryos 
would not culture beyond the 2-cell stage. This 2-cell 
block phenomenon would allow 1-cell embryos to complete 
the first cleavage division, but the embryos would not 
progress to the 4-cell stage in culture (Cole and Paul, 
1965). Whitten and Biggers (1968) determined the 2-cell 
block phenomenon to be geneticly dependent; some mouse 
strains could not be cultured, unless 2-cell PIEs were 
present at recovery. Abramczuk, et al. (1977), working 
with Whitten's new medium, determined that the addition 
of ethylenediaminetetraacetic acid (EDTA) would allow all 
one-cell mouse embryos to complete development to the 
blastocyst stage. EDTA has the ability to chelate 
divalent cations, an action essential to the development 
of l~celled embryos. The addition of EDTA to Whitten's 
new medium enhances the versatility of the culture medium 
for PIE culture. This modification is widely used by 
researchers, and is commonly called Whitten's Modified 
Medium (Table 1). 
15 
Initiation of the Embryonic Genome 
.The development of molecular techniques provided 
researchers the opportunity to perform biochemical 
analysis of mammalian embryos to better understand the 
control mechanisms for early embryogenesis (Epstein, 
1975). During oogensis, oocytes were shown to accumulate 
a large volume of maternal macromolecules that resulted 
in a 350-fold increase in oocyte size (Magnuson and 
Epstein, 1987). Maternal macromolecules accumulated 
included all classes of RNA, and a variety of proteins. 
The end of the growth phase was marked by a decline in 
RNA synthesis to an undetectable level. The mature 
oocytes contained sufficient RNA for the synthesis of 
proteins through the 2-cell stage, following 
fertilization (Chen, et al., 1980; Schultz, 1986; 
Magnuson and Epstein, 1987). 
Synthesis and modification of proteins during oocyte 
maturation, fertilization, and the first cleavage 
division (2-cell stage) resulted in various protein 
patterns, as determined by electrophoretic studies 
(Braude, et al., 1979; Howlett and Bolton, 1985). 
studies have shown that variations in protein patterns, 
from oocyte maturation through fertilization, were 
intrinsically regulated as a result of post-translational 
modifications of pre-existing proteins (Van Blerkom, 
16 
1981a and 1985; Van Blerkom and Runner, 1984). Changes 
in the protein patterns, from fertilization through the 
2-cell stage, resulted from the occurrence of protein 
synthesis utilizing maternally-derived mRNA's 
(Van Blerkom, 1981a and 1985; Van Blerkom and Runner, 
1984) . 
Several published reports have concluded that 
initiation of the expression of the embryonic genome 
occurs late in the 2-cell stage and continues through 
development; the genome replaces the influence of the 
maternal mRNA in the synthesis of proteins. Dramatic 
changes in protein synthesis occurred following the first 
cleavage division. Prior to the second cleavage 
division, there was a 6- to 8-fold increase in protein 
synthetic activity, which was attributed to the 
initiation of the embryonic genome (Schultz, 1986). 
Schuitz confirmed that the control of early embryo-
genesis, through the 2-cell stage, was regulated by 
macromolecules accumulated during oocyte maturation. 
Using data reported by other researchers, Schultz 
supported his conclusions concerning the control of early 
embryogenesis. From fertilization through the 2-cell 
stage, PIEs lose 70 - 90% of their maternal mRNA 
(Giebelhaus, et al., 1983), and the·synthesis of proteins 
has been shown to remain at a constant rate (Brinster, et 
17 
al., 1976). Within the first 24 hours following 
fertilization, 40% of the bulk maternal RNA (Bachvarova 
and DeLeon, 1980), 70% of the total polyadenlyated RNA 
(Levey, et al., 1978; Piko and Clegg, 1982), and 
approximately 90% of the histone mRNA (Graves, et al., 
1985) and actin mRNA (Giebelhaus, et al., 1985) had been 
degraded. Levels of RNA synthesis were reported to be 
low in fertilized ova, but the lowered levels were 
followed by a rapid increase in the synthesis of all RNA 
classes by the late 2-cell stage (Young, et al., 1978; 
Pike and Clegg, 1982; Clegg and Piko, 1983a, and b). 
Earlier, Moore (1975) reported the absence of detectable 
RNA polymerase in embryos prior to the attainment of the 
2-cell stage. Further evidence to support Schultz's 
conclusion were manifest in reports that changes in the 
protein pattern, from fertilization through the 2-cell 
stage, were either post-transcriptional modifications of 
proteins or the result of protein synthesis utilizing 
maternally-derived mRNA's (Braude, et al., 1979; 
Petzoldt, et al., 1980; Van Blerkom, 1981a and 1985; 
Van Blerkom and Runner, 1984). Using transcriptional 
inhibitors, such as a-amanitin and actinomycin D, Golbus, 
et al. (1973) and Warner and Versteegh (1974) 
demonstrated that early embryos were inhibited in their 
development beyond the 2-cell stage. The final evidence 
18 
offered in support of Schultz's conclusion, concerning 
embryonic genomic expression, involved the use of two 
protein genetic variants, ~-glucoronidase (Wual and 
Chapman, 1976) and ~2-microglobulin (Sawicki, et al., 
1982), to detect paternal gene expression in 2-cell 
embryos. This genetic evidence was significant because 
it was known that spermatozoa did not contribute rnRNA to 
the developing embryo. Schultz (1986) concluded that the 
combination of biochemical and genetic observations 
supported the idea that the transition from maternal 
control to embryonic genomic control occurs in the 2-cell 
stage. 
In contrast to the idea that embryonic genomic 
expression was initiated at the 2-cell stage, Renard, et 
al. (1991) proposed that embryonic genomic expression was 
not required until the 8-cell stage. This proposal was 
based on evidence obtained by using reconstituted embryos 
from parthenogenetic and androgenetic blastomeres, fused 
together at the 4-cell stage, to produce living mice. 
These data suggested that expression of the paternal 
genomes were delayed until completion of the second 
cleavage division. 
19 
Steroid Influence 
The development of culturing procedures for pre-
implantation mouse embryos has demonstrated that viable 
embryos can be maintained through progressive stages of 
early embryogenesis in a simple-defined medium (non-
physiological), such as Whitten's Modified Medium. 
studies have shown that culturing procedures used for PIE 
research cause in vitro maintained embryos to lag 
developmentally behind embryos maintained in vivo (Bowman 
and McLaren, 19.70a and b; Spielmann, et al., 1980). 
This lag in development has been attributed to the 
absence of developmental influencing factors, present 
within the maternal reproductive tract, that enhance 
early embryo proliferation among in vivo embryos. 
Schultz (1986) has shown that early mammalian 
embryogenesis was highly dependent on the embryonic 
genome for the initiation of rapid cell proliferation and 
the onset of differentiation. 
Developmental influencing factors investigated for 
regulatory enhancement were hormones and unlimited 
supplies of energy. Hormonal influence has been the most 
widely studied of the factors thought to play a role in 
regulation of embryonic development. These studies 
focused on two aspects of hormone regulation: 
(1) exogenous steroid hormone influence (Warner and 
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Tollefson, 1977 and 1978), and (2) embryonic 
steroidogenesis (endogenous) (Dickmann, et al., 1976 and 
1977; Sengupta, et al., 1977). 
Whitten (1956b and 1957b) studied the effects of 
progesterone on mouse blastocyst in vitro development in 
8-cell PIEs. Whitten's data showed that low 
concentrations of progesterone were not inhibitory to 
blastocyst development, but progesterone concentrations 
of 4µg/ml, and above, were toxic (cleavage inhibition). 
Included in these studies were efforts to determine the 
presence of antagonistic properties of estrogen in 
progesterone treated 8-cell PIEs. Whitten (1957b) 
reported that estrogen did not provide 8-cell PIEs 
protection against the toxic effects of progesterone. 
Using the rabbit model, Daniel and Levy (1964) 
exposed PIEs to various progesterone concentrations to 
determine the inhibitory effects of progesterone on PIEs. 
These investigations demonstrated that progesterone 
levels of lOµg/ml and above, inhibited cleavage up to the 
blastocyst stage. However, blastocysts treated with 
progesterone did not exhibit inhibitory responses. It 
was demonstrated that PIE cleavage, inhibited by 
progesterone, would recover from the cleavage block when 
transferred to a medium lacking progesterone. These data 
suggested that progesterone inhibition resulted from 
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interference with the supply of essential amino acids, or 
proteins, to pre-blastocyst PIEs. Progesterone 
aggregation was believed to occur at the zona pellucida 
or on the ovum surface. 
Daniel (1964) reported that estrogen caused the 
formation of small cytoplasmic protrusions (blebs) on 
rabbit PIEs. The blebs lacked an organized nucleus and 
contained small amounts of chromosomal material. The 
formation of the blebs resulted from excessive 
subdivisions of the PIEs at a time when the nuclear 
material was mitotically reorganizing into chromosomes. 
Excessive subdivisions resulted in the inability of the 
blastomeres to distribute their nuclear material equally 
during cleavage. 
Studies involving the culture of mouse PIEs, 2-cell 
through the blastocyst stage, in the presence of 25µg/ml 
of 17-~-estradiol, or 8µg/ml of progesterone, were 
conducted by Kirkpatrick (1971). In this report, 
Kirkpatrick concluded that differential sensitivity 
indicated a definite trend toward resistance to the 
inhibitory effects of steroids as early PIEs progressed 
through development. 
The influence of 17-~-estradiol on the uptake of 
amino acids and their incorporation into proteins by 
2-cell mouse PIEs cultured through blastocyst hatching 
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was reported by Smith and Smith (1971). Early 
blastocysts showed a slight increase in amino acid uptake 
and in the incorporation of amino acids into proteins. 
Expanded blastocysts were observed to have a 
significantly higher amino acid uptake and protein 
incorporation. Hatched blastocysts (expanded blastocysts 
following the rupture of the zona pellucida) had the 
ability to uptake amino acids, but incorporation of amino 
acids into proteins was not detected, These data 
demonstrated that 17-~-estradiol directly influenced the 
preimplantation blastocysts in the uptake of amino acids. 
In addition, it was suggested that hatched blastocysts 
developed an estrogen-sensitive mechanism prior to 
implantation. In a related study using rabbit PIEs, 
El-Banna and Daniel (1972) reported that low con-
centrations of progesterone were essential to blastocyst 
development when cultured in a simple-defined medium, 
supplemented with macromolecular serum components. In 
this study, amino acid uptake was enhanced and embryo 
viability was improved. El-Banna and Daniel (1972) 
speculated that incorporated proteins acted as 
progesterone carriers. 
Investigations have shown that non-steroidal 
antiestrogens prevent estrogens from expressing their 
effects on target tissues (Clark, et al., 1973; 
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Katzenellenbogen, et al., 1979). Estrogen antagonists, 
such as nafoxidine (Ull,lOOA) and CI-628, compete with 
17-~-estradiol for specific binding sites on the same 
receptor. These antiestrogens were reported to cause the 
retention of estrogen receptors in rat uterine nuclei 
(Clark, et al., 1973 and 1974; Ferguson and 
Katzenellenbogen, 1977). The retention of the estrogen 
receptor stimulated uterine growth but inhibited the 
replacement of cytoplasmic receptors. This inability to 
stimulate the replacement of cytoplasmic receptors 
demonstrated the antagonistic properties of the non-
steroidal antiestrogens. The mechanism of action for 
estrogen and the inhibition by estrogen antagonists are 
illustrated in Figure 3. Due to the lipophilic nature of 
these molecules, the receptor recognition occurs within 
the cell boundary. Engagement of the estrogen receptor 
complex induces specific genomic sites to synthesize RNA 
and, subsequently, protein synthesis. The antagonists 
prevent this action by estrogen. 
Warner and Tollefson (1977 and 1978), working with 
a-cell and blastocyst mouse embryos, reported that RNA 
synthesis was not influenced by exogenously administered 
physiological concentrations (l0-5M - l0-9M) of 
17-~-estradiol, progesterone, or combined 
17-~-estradiol/progesterone. Included in this study were 
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Figure 3. Schematic representation of estrogen's 
mechanism of action (Mendelson, 1988). S=ligand, 
R=receptor. 
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both short-term and long-term incubation periods (0.5-24 
hours) to determine the occurrence of primary and/or 
secondary effects on RNA synthesis. Increased 
stimulation of RNA synthesis was observed when PIEs were 
exposed to 15% heated mouse serum. Following exposure to 
heated mouse serum, PIEs treated with progesterone were 
inhibited in the synthesis of RNA. 
Whitten's Medium was shown to be a highly effective 
medium for the culture of 8-cell rat PIEs to the expanded 
blastocyst stage (Roy, et al., 1981). Data showed that 
blastocyst formation was severely reduced when 3µg/ml of 
nafoxidine was added to Whitten's Medium. Administration 
of lµg/ml of 17-~-estradiol to nafoxidine treated 8-cell 
PIE cultures did not reverse the developmental inhibition 
of nafoxidine. Early blastocysts, supplemented with 
lµg/ml of 17-~-estradiol, following culture in 3µg/ml of 
nafoxidine resulted in a 60% reversal in blastocyst 
expansion (Sengupta, et al, 1982). These data 
demonstrated that 17-~-estradiol reversed the 
antiestrogenic response induced by nafoxidine in 
blastocysts. 
Overall, investigations concerning the influence of 
exogenously administered steroid hormones on protein 
synthesis and RNA synthesis, using in vitro cultured 
PIEs, have provided little evidence to support the id.ea 
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that maternally derived hormones directly influence early 
embryogensis. The paucity of evidence supporting direct 
maternal hormonal influence initiated investigations into 
the role of the embryo in endogenous steroid hormone 
production. Developmental activities related to the 
transformation of the morula to a blastocyst, as 
influenced by embryo steroidogenesis, were investigated 
by Dickmann, et al. (1976) and Sengupta, et al., (1977). 
Transformation of the morula to the blastocyst, a 
significant event in PIE development, was considered to 
be estrogen/progesterone dependent. 
Dey and Dickmann (1974) demonstrated that mouse PIEs 
possessed the steroidogenic enzymes A5-3-~-hydroxysteroid 
dehydrogenase (3~-HSD) and 17-~-hydroxysteroid 
dehydrogenase (17~-HSD). This report suggested that PIEs 
had the ability to endogenously produce steroid hormones. 
The enzyme activity of 3~-HSD was reported in 30% of the 
2-cell PIEs (Dey and Dickmann, 1974), and 17~-HSD was 
present in 2-cell PIEs (Dickmann, et al., 1976). 
Steroidogenic enzyme activity in early PIEs has been 
reported for other models: the hamster model (Dickmann 
and Sengupta, 1974), the rat model (Dickmann and Dey, 
1974), and the rabbit model (Dickmann, et al. 1975). 
Progesterone and 17-~-estradiol were reported as being 
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present in mouse blastocysts using radioimmunoassay 
techniques (Dickmann, et al., 1975 and 1976). 
Using the antiestrogen CI-628, Sengupta, et al. 
(1977) reported that PIEs were inhibited in their 
formation to blastocysts from morulas. The addition of 
17-~-estradiol allowed cultured morulas to progress to 
the blastocyst stage (Sengupta, et al., 1977, 1982, and 
1983). These data suggested that endogenous estrogen in 
PIEs played a critical role in morula-blastocyst 
transformation (Faria, et al., 1984). 
Tamoxifen 
Recent reports suggest that a new non-steroidal 
agent, tamoxifen ([Z]-2-[4-(l,2-Diphenyl-l-butenyl)-
phenoxy]-N,N-Dimethylethanamine), possesses potent 
antiestrogenic properties (Patterson, 1981). 
Antiestrogenic effects were a direct result of 
tamoxifen's ability to compete with estrogen for 
available binding sites in target tissues. Competition 
for available binding sites was reported to prevent the 
estrogen-receptor complex from forming specific 
associations with the nuclear acceptor sites. The 
formation of a tamoxifen receptor complex which directly 
associates with the embryonic genome fails to stimulate 
transcription (Jordan and Murphy, 1990). 
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Two-Dimensional Electrophoresis 
The utilization of two dimensional (2-D) gel 
elec~ropheresis, has provided researchers a method for 
the isolation and characterization of polypeptides. 
Because 2-D electrophoresis provides accurate resolution 
of polypeptides from a relatively small volume of 
experimental material, 2-D studies have been shown to be 
applicable to the study of early embryonic development. 
The number of mouse embryos used in two dimensional 
studies (2-D gels) has varied from 15 (Poueymirou et al., 
1989) to 150 PIEs (Van Blerkom, 1981a). Analyses of the 
changing pattern of protein composition in various PIE 
stages, through 2-D studies, has generated a protein 
profile for early embryogenesis. Approximately 300 
polypeptides have been resolved for mouse PIEs, oocyte 
through blastocyst stage (Chen, et al., 1980; 
Van Blerkom, 1981a; Cascio and Wassarman, 1982; Flach, 
et al., 1982; Bolton, et al., 1984; Howlett and Bolton, 
1985; Poueymirou and Schultz, 1989). 
Hypothesis 
This study will attempt to determine the influence 
of exogenously administered 17-~-estradiol on in vitro 
cultured preimplantation mouse embryos. Specifically, 
this research hypothesizes that 17-~-estradiol enhances 
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protein synthesis in 2-cell, 4-cell, and a-cell 
preimplantation embryos. This study will also attempt to 
verify the antiestrogenic properties of tamoxifen. 
Analysis of 17-~-estradiol enhancement and tamoxifen 
inhibition will be determined through comparative studies 
of the protein patterns for 2-cell, 4-cell and a-cell 
preimplantation embryos as determined through two 
dimensional electrophoretic procedures. 
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CHAPTER II 
MATERIALS AND METHODS 
Induction of superovulation 
Preimplantation embryos (PIEs) were collected from 
hormone-stimulated female Swiss Webster albino mice 
(Harlan Sprague Dawley, Inc.) that were 4-10 weeks of 
age. Mice were maintained under a controlled light regime 
in the Morehead state University Animal Facility. An 
alternating 12-hour light/dark photoperiod was 
maintained, with the midpoint of the dark period 
occurring at 12:00 a.m. Mice were fed Purina mouse chow 
(Ralston Purina Company) and water ad libitum. 
Estrus initiation in the experimental mice was 
induced by injecting gonadotropin [pregnant mares' serum 
gonadotropin (PMSG)] into the peritoneal cavity (Fowler 
and Edwards, 1957; Gates and Dronkert, 1965). Female 
mice were given intraperitoneal injections of 5 
internation~l units (5 IU) of PMSG (Sigma Chemical Co.); 
(Warner and Tollefson, 1978; personal communication: 
Reid), in 0.05-cc volume using a 1-cc syringe with a 
26 2/3-gauge needle. PMSG induction was initiated at 
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12:00 p.m. for each experimental group to synchronize the 
subsequent hCG injections, and the recovery of PIEs 
(Figure 4). Human chorionic gonadotropin (hCG, Sigma 
Chemical Co.) injections of 5 IU (Warner and Tollefson, 
1978; personal communication: Reid), in 0.05-cc volume 
using a 1-cc syringe with a 26 2/3-gauge needle, were 
intraperitoneally administered 45 hours post-PMSG 
injection (9:00 a.m.). Following the hCG injection, each 
female mouse was placed in a separate breeding cage with 
a fertile male. At 20 hours post-hCG injection (8:00 
a.m.r, each female mouse was examined for the presence of 
a vaginal plug (sperm plug) to verify copulation 
(Poueymirou and Schultz, 1987). 
Females with vaginal plugs were separated from males 
and maintained in separate cages until the proper time 
for the extraction of PIEs. Those females that failed to 
copulate were returned to the colony and again stimulated 
with PMSG and hCG, following a waiting period of 7-10 
days. 
Embryo Recovery 
-Preimplantation embryo recovery was made at 45 
(2-cell), 54 (4-cell), and 62 (8-cell) hours post-hCG 
injection (Brinster, 1965a and 1967; Warner and 
Tollefson, 1978). Female mice were sacrificed by 5 IU 
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Two Dimensional Gel Electrophoresis 
Figure 4. outline of laboratory experimentation. 
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cervical dislocation and the skin was removed from the 
ventral abdominal wall to prevent hair contamination 
during oviduct excision. Skin removal was accomplished 
by making a mid-ventral incision the length of the 
abdominal cavity, and two lateral incisions below the rib 
cage. sterile forceps were used to retract the skin and 
expose the entire abdominal wall. The viscera were 
exposed by making two lateral incisions just anterior to 
the posterior legs and continuing along the lateral 
abdominal wall to the rib cage. The muscle flap was 
lifted forward between the forelegs to allow gross 
observation of the viscera in the lower abdominal cavity. 
To expose the uterine horn and oviduct on each side of 
the abdominal cavity, the digestive tract and fat 
deposits were moved from side to side. 
To remove each oviduct, microdissection scissors 
were used to bisect the uterine horn anterior to the body 
of the uterus. Watchmaker's forceps were used to grasp 
the free end of the uterine horn and lift the oviduct 
from the abdominal cavity. Connective tissue was removed 
from the uterine horn, using microdissection scissors. 
The oviduct was excised by cutting the bursa at the 
ovarian end of the reproductive tract (Schneider, 1970). 
Following excision, each oviduct was positioned on a 
glass plate flooded with Whitten's Modified Medium 
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(Abramczuk, et al., 1977; Poueymirou, et al., 1989). A 
standard pedestal dissecting microscope (American 
Optical: 7-42 zoom) was used to separate each oviduct 
from the uterus; dissection was made at the uterotubal 
junction (Weldon, 1971). Each oviduct was transferred to 
a clean pool of Whitten's Modified Medium. A blunted 
JO-gauge needle, attached to a 1-cc syringe containing 
Whitten's Modified Medium, was inserted into the 
fimbriated end of the oviduct (Lyon, 1971). The PIEs 
were_flushed by gently forcing medium through the oviduct 
and embryos were collected in a depression slide 
containing culture medium. PIEs were immediately washed 
in two baths of culture medium; transfers were made 
using an Eppendorf micropipetor, set at 2µ1, with a gel 
loading tip. The transfers were designed to wash the 
embryos by removing cellular debris (cumulus and red 
blood cells) from the culture medium (Brinster, 1967). 
Following the second bath, the PIEs were transferred to 
culture dishes containing Whitten's Modified Medium, and 
placed in an incubator. 
Embryo Culture 
Preimplantation mouse embryos were recovered and 
cultured in Whitten's Modified Medium (Abramczuk, et al. 
1977). The modification of Whitten's Medium (Whitten, 
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1971) was made by adding ethylenediaminetetraacetic acid 
(EDTA). The modification was made to utilize the 
chelating action of EDTA in the removal of divalent metal 
cations (Abramczuk, et al. 1977). 
Whitten's Modified Medium (100-ml volumes) was 
prepared each week. The components and concentrations in 
Whitten's Modified Medium are shown in Table 2. Protocol 
for medium preparation was according to Whitten (1971), 
with the addition of 1ml of a l0mM EDTA solution (l00mM 
concentration of EDTA in the medium) prior to the 
addition of crystalline bovine serum albumin (Poueymirou 
and Schultz, 1989). The medium was gassed with 5% co2 in 
air (Whitten, 1971), until a pH value between 6.8-7.2 was 
obtained (Brinster 1965a). Following the pH adjustment, 
the medium was filtered using a disposable filter 
apparatus (Nalge 120 Nalgene, Inc.), with a 0.2 micron 
filter (Whitten, 1971). After filtration, the medium was 
transferred to a culture flask, inside a bioflow hood, 
and refrigerated at 4°c until it was used. Fresh culture 
medium was prepared weekly. 
Prior to sacrificing the mice, portions of the 
culture medium were transferred to an incubation chamber 
and kept for 30 minutes at 370c in a humid atmosphere of 
5% co2 in air. This procedure assured that optimal 
culture conditions were provided. The medium was 
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Table 2. Medium Formulation (Whitten, 1971). 
Component Concentration/100ml 
NaCl 514.00 mg 
KCl 36.00 mg 
KH2Po4 16.00 mg 
MgSO47H2O 29.00 mg 
NaHCO3 190.00 mg 
Na Pyruvate 3.50 mg 
Ca Lactate 5H2O 53.00 mg 
Glucose 100.00 mg 
K Penicillin G 8.00 mg 
streptomycin so4 5.00 mg 
Double Distilled H2O 100.00 ml 
60% Sodium Lactate 0.37 ml 
1% Phenol Red 0.10 ml 
10mM EDTA 1.00 ml 
Bovine Serum Albumin 300.00 mg 
dispensed in 1-ml aliqouts to the center well of an organ 
culture dish (15x60, Falcon Plastics). An additional 
10ml of the medium was transferred to a 25-ml Erlenmeyer 
flask, and placed in the incubation chamber. The 
additional volume of medium was used for the recovery of 
PIEs. 
Experimental protocol required the recovery of PIEs 
in three different embryonic stages: (1) 2-cell stage 
(42 hrs post-hCG); (2) 4-cell stage (56 hrs post-hCG); 
and (3) 8-cell stage (64 hrs post-hCG). After recovery 
and preincubation washes, groups of ten embryos for each 
developmental stage were transferred to the 1 ml aliquots 
of Whitten's Modified Medium in the center well of the 
organ culture dishes. According to the protocol flow 
sheet (Figure 4), PIEs were cultured for 8 hours in one 
of five treatment groups. Treatment groups were: 
Treatment Group I: Medium plus lµg 17-~-estradiol 
(3.4xl0-3mM) in 50µ1 absolute ethanol-saline (l.4xl0-2mM 
absolute ethanol; 0.9% NaCl solution); 
Treatment Group II: Medium plus 50µ1 of absolute 
ethanol-saline (l.4xl0-2mM absolute ethanol; 0.9% NaCl 
solution); 
Treatment Group III: Medium only; 
Treatment Group IV: Medium plus 3µg tamoxifen; 
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Treatment Group V: Medium plus 3µg tamoxifen and 
lµg 17-13-estradiol in 50µ1 absolute ethanol-saline 
(l.4xl0-2mM absolute ethanol; 0.9% NaCl solution). 
Steroids and antisteroid solutions for each 
treatment group were prepared, as stock solutions, to 
permit the direct delivery of each treatment to the 
culture dish containing 10 PIEs. The 17-13-estradiol 
stock solution (Sigma Chemical Co.), used in Treatments I 
and v, was prepared in absolute ethanol to establish a 
lµg/ml (3.6mM) solution (Roy, et al., 1981). The 
concentration of lµg/ml of 17-13-estradiol was selected as 
a result of published reports that such treatments would 
not have deleterious effects on PIE development (Roy, et 
al., 1982; Warner and Tollefson, 1977). Following the 
preparation of the 17-13-estradiol stock solution, the 
solution was diluted with sterile saline (0.9% NaCl) 
(Sengupta, et al., 1982) to obtain a 20µg/ml (7.3xl0-2mM) 
17-13-estradiol solution with an ethanol concentration of 
4.2xl0-1mM (Roy, et al., 1982). A 50µ1 aliquot of the 
17-13-estradiol solution was added to the culture dishes 
containing 10 PIEs for Treatments I and V. Treatment 
concentration within the culture medium was lµg for 
17-/3-estradiol (3.4xl0-3mM) and l.4xl0-2mM concentration 
of ethanol (Roy, et al., 1982). 
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Treatment II was identical to Treatment I, except 
17-~-estradiol was not added to the stock solution. 
Because the 17-~-estradiol used in Treatment I was 
ethanol soluble, Treatment II was necessary to 
differentiate between the effects of ethanol and 
17-~-estradiol. 
Preimplantation embryos in Treatment III were 
maintained in Whitten's Modified Medium to serve as an 
experimental control. 
The tamoxifen (Sigma Chemical Co.) stock solution 
was prepared by dissolving 1mg of tamoxifen in 50µ1 of 
absolute ethanol, and the volume was increased to 1ml 
with sterile saline. The addition of sterile saline 
produced a lµg/ml tamoxifen solution for use in 
Treatments IV and v. Tamoxifen, a non-steroid estrogen 
blocker, was used in Treatment IV as the only variable to 
determine its effects on PIEs. Three microliters of the 
tamoxifen solution (3µg) were added to the culture dishes 
used in Treatment IV. Tamoxifen treatments of 3µg/ml 
were derived from published reports for the antiestrogen 
nafoxidine (Ull, l00A). Roy, et al. (1981) demonstrated 
that 3µg/ml of nafoxidine was effective in the inhibition 
of blastocyst expansion in mouse PIEs. 
Embryos cultured in Treatment V were exposed to both 
tamoxifen and 17-~-estradiol. Following the transfer of 
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the embryos to the culture dishes, 3µ1 of the tamoxifen 
solution (Jµg) was added to Treatment v. Fifteen minutes 
after the beginning of the incubation period, 50µ1 of the 
17-~-estradiol solution was added to the culture dishes 
in Treatment V. Delayed administration of 17-~-estradiol 
permitted tamoxifen sufficient time to bind estrogen 
receptors. 
Culture experiments using 2-cell, 4-cell and a-cell 
PIEs -were conducted in units of 10 embryos with 6 
replicas for each treatment group; 60 PIEs were cultured 
per treatment group for each embryonic stage. Randomized 
replicas were conducted to increase sample size and to 
minimize the effects of systemic errors. 
For Treatment Groups I, II, IV and V, the addition 
of steroids and antisteroid solutions immediately 
followed the transfer of 10 PIEs to culture dishes. 
Incubation was maintained for a hours at 37°c in an 
atmosphere of 5% co2 in air. At the conclusion of the 
eight-hour incubation period, PIEs were then examined for 
viability. Viability was determined by progression of 2-
cell, 4-cell and a-cell PIEs to 4-cell, a-cell, and 
morula stages, respectively. PIEs that failed to advance 
during the culture period were inhibited in their 
development by a treatment or they were inviable. 
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PIEs recovered were transferred, as a group of 10, 
to 1.5-ml microfuge tubes containing 10µ1 of triton-X-100 
sample buffer (lysis buffer) (O'Farrell, 1975). The 
microfuge tubes were stored at -7o0 c for later analysis. 
To determine significance between PIE treatment 
groups, the standard normal z-statistic was used at 
p<0.05. 
Two-Dimensional Gel Electrophoresis 
Treatment Groups I-V of frozen preimplantation mouse 
embryos, were prepared for analysis by two-dimensional 
(2-D) gel electrophoresis. Resultant 2-D gels would 
provide individual protein profiles for the various 
treatment groups. 
Sample preparation was effected in lysis buffer, and 
involved a series of freeze-thaw cycles to enhance cell 
lysis and the suspension of the polypeptides in solution. 
Lysis was followed by centrifugation for 15 minutes at 
14,000 rpm. Three preimplantation embryo samples, each 
containing 10 solubilized embryos, were combined for 
electrophoretic studies; 30 treated PIEs per gel 
(Poueymeitou, et al., 1989). condensed samples were 
frozen at -7o0 c and, prior to use, were cycled through a 
freeze~thaw process and centrifuged for 15 minutes at 
14,000 rpm with a Eppendorf Model 5415 Microcentrifuge 
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(Brinkmann). Following polypeptide suspension, samples 
were subjected to 2-D gel electrophoresis according to 
the method described by O'Farrell (1975), and revised by 
Dunn and Burghes (1983a and b). 
·Isoelectric focusing (IE_F) constituted the first 
dimension of 2-D electrophoresis. During IEF, 
po_lypeptides were separated on the basis of their 
isoelectric points. IEF of PIE samples was performed 
using ampholytes with a pH range of 5 to 7 and 3.5 to 10 
(Pharmacia, LKB) in 1.0mm inner diameter tubes. Tube gel 
electropheresis was run at 400 volts for 12 hours. The 
limit values of the pH gradient were 4.65 and 9.60 as 
determined by IEF standards (Bio Rad). 
Following IEF, the tube gels were placed on top of 
SDS polyacrylamide gels, which included a 4% stacking gel 
and a 10% resolving gel. In the second dimension, the 
poly-peptides were separated on the basis of their 
molecular weights. O'Farrell's (1975) procedure was 
modified by substituting diacylylpiperazine (PDA; 
BioRad) for bis-acrylamide as the cross-linker in 
SDS-PAGE (Hochstrasser, et al., 1988). Following 2-D gel 
electrophoresis, the gels were silver stained according 
to the method of Wray, et al. (1981), and a polypeptide 
map was constructed at each embryonic stage. Individual 
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proteins were characterized according to their molecular 
weight and apparent isoelectric (pI) values. 
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CHAPTER III 
RESULTS 
Viability Data 
Preimplantation embryos were examined for viability 
following the 8 hour incubation period. Cultured embryos 
for each treatment group were observed to determine the 
occurrence of cleavage during incubation. Data obtained 
for 2-cell PIEs incubated for 8 hours in Whitten's 
Modified Medium are presented in Table 3 by treatment 
group. Control Treatment Groups II (ethanol~saline) and 
III (medium control) yielded 76.6% and 80% progression to 
the 4-cell stage following incubation. Thus, the 
addition of 50µ1 of ethanol-saline to Whitten's Modified 
Medium was without effect. Therefore, Treatment Group II 
was used in all viability comparisions as the 
experimental control. 
PIEs in Treatment Group I were incubated in the 
presence of 17-~-estradiol. Following incubation, 11 of 
60 (18.3%) of the PIEs had advanced to the 4-cell stage, 
a significant (p<0.05) reduction in embryonic progression 
as compared to the experimental control. In Treatment 
Group IV, PIEs were cultured in the presence of tamoxifen 
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Table 3. Interaction of 17-B-estradiol and tamoxifen on the progression of 
2-cell mouse preimplantation embryos in vitro culture for 8-hours. 
Experimental No. of 
Group Schedule Replica 
I 17-B-Estradiol 6 
II Ethanol-Saline 6 
III Medium Control 6 
IV Tamoxifen 6 
V Tamoxifen + 
17-B-Estradiol 6 
Concentration 
of 
Drug/Vehicle 
per ml 
lug 
50ul 
3ug 
3ug + lug 
Total No. 
of 
2-Cell 
Embryos 
Cultured 
60 
60 
60 
60 
60 
~Significant at p < .05 from control group II 
Significant at p < .05 from treatment group V 
Total No. 
of 
Advancing 
2-Cell Embryos 
11a,b 
46 
48 
49 
25a 
% of 2-Cell 
Embryos 
Advancing 
after 8 hours 
Culture 
18.3 
76.6 
80.0 
81. 6 
41. 6 
and al.6% advanced to the 4-cell stage, a value similar 
to that of the experimental control. Embryos cultured in 
Treatment Group V were exposed to both tamoxifen and 
17-~-estradiol. Following incubation, 41.6% of the PIEs 
advanced to the 4-cell stage, a significant (p<0.05) 
decrease from the experimental control. When Treatment 
Group V was compared to Treatment Group I, there was also 
a significant (p<0.05) increase in the number of PIEs 
progressing to the 4-cell stage suggesting a possible 
block of 17-~-estradiol by tamoxifen. 
Data obtained for 4-cell PIEs incubated for a hours 
in Whitten's Modified Medium are presented in Table 4 by 
treatment group. Control Treatment Groups II (ethanol-
saline) and III (medium control) both yielded 70% 
progression to the a-cell stage following incubation. 
PIEs in Treatment Group I, incubated in the presence 
of 17-~-estradiol, showed that 70% of the PIEs had 
advanced to the a-cell stage. The 17-~-estradiol 
treatment produced results equal to that of the 
experimental control (Group II). In Treatment Groups IV 
(tamoxifen only) and V (tamoxifen plus 17-~-estradiol), 
11 of 60 PIEs (la.3%) advanced to the a-cell stage, a 
significant (p<0.05) decrease from the experimental 
control. Thus, tamoxifen by itself or in the presence of 
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Table 4. Interaction of 17-B-estradiol and tamoxifen on the progression of 
4-cell mouse preimplantation embryos in vitro culture for 8-hours. 
Experimental No. of 
Group Schedule Replica 
I 17-B-Estradiol 6 
II Ethanol-Saline 6 
III Medium control 6 
IV Tamoxifen 6 
V Tamoxifen + 
17-B-Estradiol 6 
Concentration 
of 
Drug/Vehicle 
per ml 
lug 
soul 
3ug 
3ug + lug 
Total No. 
of 
4-Cell 
Embryos 
Cultured 
60 
60 
60 
60 
60 
asignificant at p < .05 from control group II 
Total No. 
of 
Advancing 
4-Cell Embryos 
42 
42 
42 
lla 
lla 
% of 4-Cell 
Embryos 
Advancing 
after 8 hours 
Culture 
70.0 
70.0 
70.0 
18.3 
18.3 
17-~-estradiol, was effective in reducing viability at 
the 4-cell stage. 
Data obtained for a-cell PIEs incubated for a hours 
in Whitten's Modified Medium are presented in Table 5 by 
treatment group. control Treatments Group II (ethanol-
saline) and III (medium control) yielded a6.6% and a5% 
progression to the morula stage following incubation. 
Again, Treatment Group II was used as the experimental 
control. 
'Following incubation, in the presence of 17-~-
estradiol (Group I), al.6% of the PIEs had advanced to 
the morula stage; results that were similar to that of 
the experimental control. In Treatment Group IV, PIEs 
cultured in the presence of tamoxifen showed that only 17 
of 60 (2a.3%) advanced to the morula stage, a significant 
(p<0.05) reduction in embryonic progression as compared 
to the experimental control. Nineteen of 60 (31.6%) 
embryos exposed to both tamoxifen and 17-~-estradiol 
(Group V), advanced to the morula stage, a significant 
(p<0.05) decrease from the experimental control. Again, 
as was evident at the 4-cell stage, tamoxifen blocked or 
retarded the cleavage in a-cell PIEs. 
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Table 5. Interaction of 17-B-estradiol and tamoxifen on the progression of 
a-cell mouse preimplantation embryos in vitro culture for 8-hours. 
Experimental No. of 
Group Schedule Replica 
I 17-B-Estradiol 6 
II Ethanol-Saline 6 
III Medium Control 6 
IV Tamoxifen 6 
V Tamoxifen + 
17-B-Estradiol 6 
Concentration 
of 
Drug/Vehicle 
per ml 
lug 
50ul 
3ug 
3ug + lug 
Total No. 
of 
8-Cell 
Embryos 
cultured 
60 
60 
60 
60 
60 
asignificant at p < .05 from control group II 
Total No. 
of 
Advancing 
8-Cell Embryos 
49 
52 
51 
17a 
19a 
% of 8-Cell 
Embryos 
Advancing 
after 8 hours 
Culture 
81.6 
86.6 
85.0 
28.3 
31. 6 
U1 
0 
Electrophoretic Data 
Comparative studies of the protein content in 
2-cell, 4-cell and a-cell cultured PIEs were conducted 
using high-resolution, two-dimensional polyacrylamide gel 
electrophoresis. Protein profile maps for Treatment 
Groups II (ethanol-saline) and III (medium control), were 
determined to be equal within each embryonic stage 
(2-cell, 4-cell, and a-cell). Because Treatment Group II 
was considered as the experimental control for the 
viability studies, comparisons of protein profiles 
between treatment groups were made using the polypeptide 
map of this treatment group at each stage. The 2-D gel 
and polypeptide map for Treatment Group II resulted in 
the identification of n- proteins and each was assigned a 
number. Additional proteins characterized in Treatment 
Groups I, IV, and V, but not found in Group II, were 
assigned letters. 
Protein profiles for 2-cell PIEs, as a result of 2-D 
gel electrophoresis, are presented in Figures 5 - 8. The 
2-D gel and polypeptide map for Treatment Group II 
resulted in the identification of 57 proteins (Figure 5). 
Treatment Group I, 2-cell PIEs incubated in the 
presence of 17-~-estradiol, yielded a polypeptide map 
with 57 proteins (Figure 6). Proteins 15, 47 - 49 and 50 
were absent in Treatment Group I. Proteins A - E were 
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Figure 5. Two-dimensiona l gel electrophoresis of 2-cell 
PIEs incubated in the ethanol control (Treatment Group 
II). Thirty PIEs were loaded on to the gel. The upper 
panel is a silver stained 2-D gel and the lower panel is 
a polypeptide map in which numbers or letters have bee n 
assigned to represent each silver stained spot . The 
labeled polypeptides were tabulated in Table 6 for thei r 
MW and apparent pl value s . 
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Figure 6. Two- dimensional gel electrophoresis of 2-cell 
PIEs incubated in the prensce of l µg of 17-~-estradiol 
(Treatment Group I). Thirty PIEs were loaded on to the 
gel. The upper panel is a silver stained 2-D gel and the 
lower panel is a polypeptide map in which numbers or 
letters have been assigned to represent each silver 
stained spot. The labeled polypeptides were tabulated in 
Table 6 for their MW and apparent pI values. 
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Figure 7 . Two-dimensional gel electrophoresis of 2-cell 
PIEs incubated in the presence of 3µg of tamoxifen 
(Treatment Group IV). Thirty PIEs were loaded on to the 
gel. The upper panel is a silver stained 2-D gel and the 
lower panel is a polypeptide map in which numbers or 
letters have been assigned to represent each silver 
stained spot. The labeled polypeptides were tabulated in 
Table 6 for their MW and apparent pI values. 
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Figure 8. Two-dimensional gel electrophoresis of 2-cell 
PIEs incubated in the presence of 3µg of tamoxifen and 
lµg of 17-~~estradiol (Treatment Group V). Thirty PIEs 
were loaded on to the gel. The upper panel is a silver 
stained 2-D gel and the lower panel is a polypeptide map 
in which numbers or letters have been assigned to · 
represent each silver stained spot. _The _labeled 
polypeptides were tabulated in Table 6 for their MW and 
apparent pI values. 
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Table 6. Characteristics of 2-cell preimplantation 
embryos separated by two-dimensional 
polyacrylamide gel electrophoresis. #1: 
ethanol-saline control, #2: 17-~-estradiol, 
#3: tamoxifen, #4: tamoxifen + 17-~-estradiol. 
Spot# 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
MW 
(kDal 
106 
106 
105 
107 
107 
104 
104 
105 
105 
105 
95 
104 
90 
87 
94 
92 
87 
85 
101 
101 
94 
89 
84 
81 
79 
73 
81 
79 
79 
76 
75 
76 
75 
76 
71 
66 
59 
Apparent 
pJ_ 
>9.6 
>9.6 
9.2 
8.7 
8.4 
8.1 
7.8 
7.5 
7.2 
6.9 
>9.6 
8.7 
9.0 
9.0 
7.9 
7.9 
7.7 
7.7 
6.7 
6.3 
6.0 
5.9 
6.8 
6.0 
5.9 
5.9 
9.0 
9.0 
8.1 
8.3 
7.9 
7.5 
7.3 
6.9 
6.4 
7.2 
8.8 
Protein's Presence (+) 
pr Absence(-) in gels 
ll 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
li 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
ll 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
li 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
56 
57 
Table 6. Continued. 
Protein's Presence (+) 
or Absence C-l in gels 
MW Apparent 
Spot j/ (kDa) Pl. ll n ll li 
38 56 8.8 + + + + 
39 61 7.8 + + + + 
40 62 7.3 + + + + 
41 63 7.0 + + + + 
42 60 6.6 + + + + 
43 69 <4.65 + + + + 
44 64 4.6 + + + 
45 51 9.1 + + + + 
46 47 9.1 + + + + 
47 53 7.8 + 
48 50 a.a + + 
49 52 7.8 + 
50 49 7.7 + 
51 51 7.0 + + + + 
52 36 7.4 + + + 
53 45 6.3 + + + + 
54 48 6.2 + + + + 
55 51 5.8 + + + + 
56 52 4.9 + + + + 
57 34 4.7 + + + 
A 102 9.3 + + 
B 80 6.2 + + + 
C 76 5.7 + + + 
D 60 8.5 + + + 
E 42 5.3 + 
F >31 5.9 + 
G 72 6.9 + 
H 37 8.9 + 
present in Treatment Group I, but absent in Treatment 
Group II. 
Tamoxifen supplemented 2-cell PIEs in Treatment 
Group IV generated a polypeptide map composed of 56 
proteins (Figure 7). Proteins 47 - 50 and 52 were 
absent, however, proteins B - D, and F were present in 
Treatment Group IV • 
. Treatment Group v, supplemented with tamoxifen and 
17-~-estradiol, produced a polypeptide map identifying 58 
proteins (Figure 8). Proteins 44, 47, 49, 50, and 57 
were absent, however, proteins A - D, G, and H were 
present in Treatment Group V. Data for 2-D gel electro-
phoresis on all 2-cell PIEs are presented in Table 6. 
Protein profiles for 4-cell PIEs are shown in 
Figures 9 - 12. The 2-D gel and polypeptide map for 
Treatment Group II produced a total of 71 proteins 
(Figure 9). 
Treatment Group I, 4-cell PIEs incubated in the 
pres~nce of 17-~-estradiol yielded a polypeptide map with 
69 proteins (Figure 10). Proteins 2, 3, and 53 were 
absent. Protein A was present in Treatment Group I, but 
absent in Treatment Group II. 
Tamoxifen supplemented 4-cell PIEs, Treatment Group 
IV, generated a polypeptide map composed of 45 proteins 
(Figure 11). Proteins 11 - 15, 17, 18, 21, 23, 24, 27, 
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Figure 9. Two-dimensional gel electrophoresis of 4-cell 
PIEs incubated in the ethanol control (Treatment Group 
II). Thirty PIEs were loaded on to the gel. The upper 
panei is a silver stained 2-D gel and the lower panel is 
· a polypeptide map in which numbers or letters have been 
assigned to represent each silver stained spot. The 
labeled polypeptides were tabulated in Table 7 for their 
MW and apparent pr values. 
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Figure 10. Two-dimensional gel electrophoresis of 4-cell 
PIEs incubated in the presence of lµg of 17-~-estradiol 
(Treatment Group I). Thirty PIEs were loaded on to the 
gel. The upper panel is a silver stained 2-D gel and the 
lower panel is a polypeptide map in which numbers or 
letters have been assigned to represent each silver 
stained spot. The labeled polypeptides were tabulated in 
Table 7 for their MW and apparent pI values. 
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Figure 11. Two-dimensional gel electrophoresis of 4-cell 
PIEs incubated in the presence of 3µg of tamoxifen 
(Treatment Group IV). Thirty PIEs were loaded on to the 
gel. The upper panel is a silver stained 2-D gel and the 
lower panel is a polypeptide map in which numbers or 
letters have been i;tssigned to represent each silver 
stained spot. The labeled polypeptides were tabulated in 
Table 7 for their MW and apparent pI values. 
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Figure 12. Two-dimensional gel electrophoresis bf 4-cell 
PIEs incubated in the presence of 3µg of tamoxifen and 
lµg of 17-~-estradiol (Treatment Group V). Thirty PIEs 
were loaded on to the gel. The upper panel is a'silver 
stained 2-D gel and the lower panel is a polypept}de map 
in which numbers or letters have been assigned to 
represent each silver stained spot. The labeled 
polypeptides were tabulated in Table 7 for their MW and 
apparent pI values. 
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Table 7. Characteristics of 4-cell preimplantation 
embryos separated by two-dimensional 
polyacrylamide gel electrophoresis. #1: 
ethanol-saline control, #2: 17-~-estradiol, 
#3: tamoxifen, #4: tamoxifen + 17-~-estradiol. 
Spot j/ 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
MW 
(kDal 
111 
106 
105 
107 
104 
102 
102 
103 
104 
105 
98 
98 
96 
96 
98 
93 
92 
90 
81 
83 
91 
92 
91 
92 
81 
95 
92 
95 
94 
91 
90 
90 
83 
82 
80 
75 
73 
Apparent 
Pl. 
>9.6 
>9.6 
9.2 
8.7 
8.3 
8.0 
7.7 
7.4 
7.2 
7.0 
9.2 
9.0 
8.9 
8.7 
8.6 
8.1 
8.3 
8.3 
8.0 
7.7 
7.7 
7.3 
7.4 
7.2 
7.0 
6.6 
6.6 
6.2 
6.0 
6.0 
6.4 
6.3 
5.8 
6.0 
6.7 
6.1 
5.9 
Protein's Presence(+) 
pr Absence C-l in gels 
ll 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
ll 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
ll 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
li 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
63 
64 
Table 7. Continued. 
Protein's Presence (+) 
or Absence (-) in gels 
MW Apparent 
Spot# (kDa) P! ll ll ll li 
38 69 5.8 + + + + 
39 65 5.5 + + + + 
40 64 5.8 + + + + 
41 62 5.8 + + 
42 85 9.3 + + + + 
43 81 9.3 + + + + 
44 85 9.0 +· + + + 
45 73 9.2 + + + + 
46 71 9.2 + + + + 
47 70 8.5 + + + + 
48 69 7.8 + + + + 
49 69 8.5 + + 
50 68 7.5 + + + + 
51 70 7.3 + + + 
52 69 6.9 + + + + 
53 65 7.3 + - + 
54 64 6.2 + + + + 
55 50 9.0 + + + + 
56 49 8.8 + + 
57 50 8.5 + + + + 
58 53 7.8 + + + + 
59 55 7.3 + + + + 
60 56 7.0 + + + + 
61 50 6.8 + + 
62 44 9.4 + + 
63 39 9.4 + + + + 
64 40 9.0 + + 
65 38 8.4 + + 
66 38 8.6 + + 
67 38 6.4 + + + + 
68 41 6.1 + + 
69 38 6.2 + + 
70 43 5.8 + + 
71 31 7.3 + + 
A 92 6.9 - + 
B 42 7.8 - - + 
C 82 9.3 - - - + 
31, 32, 36, 41, 49, 56, 61, 62, 64 - 66, and 68 - 71 were 
absent in Treatment Group IV. Protein B was present in 
Treatment Group IV, but absent in Treatment Group II. 
Treatment Group V, supplemented with tamoxifen and 
17-~-estradiol, produced a polypeptide map identifying 43 
proteins (Figure 13). Proteins 11 - 15, 17, 18, 21, 23, 
24, 27, 31, 35, 36, 41, 49, 51, 53, 56, 61, 62, 64 - 66, 
and 68 - 71 were absent in Treatment Group V. Protein C 
was present in Treatment Group V, but absent in Treatment 
Group II. Data for 2-D gel electrophoresis on all 4-cell 
PIEs are presented in Table 7. 
Protein profiles for a-cell PIEs are presented in 
Figures 13 - 16. The 2-D gel and polypeptide map for 
Treatment Group II produced a total of 48 proteins 
(Figure 13). 
Treatment Group I, a-cell PIEs incubated in the 
presence of 17-~-estradiol yielded a polypeptide map with 
50 proteins (Figure 14). Proteins 1, 20 and 42 were 
absent in Treatment Group I. Proteins A - D and E were 
present in Treatment Group I, but absent in Treatment 
Group II. 
Tamoxifen supplemented a-cell PIEs in Treatment 
Group IV, generated a polypeptide map composed of 44 
proteins (Figure 15). Proteins 1, 16 - 20, 29, 31, 
33 - 35, 44, 46, and 47 were absent in Treatment Group 
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Figure 13. Two-dimensional gel electrophoresis of a-cell 
PIEs incubated in the ethanol control (Treatment Group 
II). Thirty PIEs were loaded on to the gel. The upper 
panel is a silver stained 2-D gel and the lower panel is 
a polypeptide map in which numbers or letters have been 
assigned to represent each silver stained spot. The 
labeled polypeptides were tabulated in Table 8 for their 
MW and apparent pI values. 
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Figure 14. Two-dimensional gel electrophoresis of .B-cell 
PIEs incubated in the presence of lµg of 17-~-estradiol 
(Treatment Group I). Thirty PIEs were loaded on to the 
gel. The upper panel is a silver stained 2-D gel and the 
lower panel is a polypeptide map in which numbers or 
letters have been assigned to represent each silver 
stained spot. The labeled polypeptides were tabulated in 
Table B for their MW and apparent pI values. 
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Figure 15. Two-dimensional gel electrophoresis of 8 - cell 
PIEs incubated in the presence of 3µg of tamoxifen 
(Treatment Group IV). Thirty PIEs were loaded on to the 
gel. The upper panel is a silver stained 2-D gel and the 
lower panel is a polypeptide map in which numbers or 
letters have been ass i gned to represent each silver 
s t ained spot. The labeled polypept ides were tabulated in 
Table 8 for their MW and apparent pI values. 
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-Figure 16. Two-dimensional gel electrophoresis of 8-cell 
PIEs incubated in the presence of 3µg of tamoxifen and 
l µg of 17-~-estradiol (Treatment Group V). Thirty PIEs 
were loaded on to the gel. The upper panel is a silver 
stained 2-D gel and the lower panel is a polypeptide map 
in which numbers or letters have been assigned to 
represent each silver stained spot. The labeled 
polypeptides were tabulated in Table 8 for their MW and 
apparent pI values. 
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Table 8. Characteristics of a-cell preimplantation 
embryos separated by two-dimensional 
polyacrylamide gel electrophoresis. #1.: 
ethanol-saline control, #2: 1.7-13-estradiol, 
#3: tamoxifen, #4: tamoxifen + 1.7-/3-estradiol. 
Protein's Presence (+) 
or Absence{-) in gels 
MW Apparent 
Spot_# {kDal ~ ll ll .u li 
1 106 >9.6 + 
2 1.08 >9.6 + + + + 
3 1.05 >9.6 + + + + 
4 102 9.3 + + + + 
5 1.02 9.0 + + + + 
6 98 9.0 + + + + 
7 98 8.6 + + + + 
8 97 8.4 + + + + 
9 97 8.2 + + + + 
1.0 97 7.9 + + + + 
1.1. 97 7.7 + + + + 
1.2 98 7.6 + + + + 
13 98 7.1 + + + + 
1.4 83 8. l. + + + + 
1.5 86 8.0 + + + 
1.6 77 9.0 + + - + 
1.7 79 7.8 + + 
1.8 75 8 .1. + + 
1.9 70 8.8 + + 
20 79 7.2 + ·-
21. 77 7.2 + + + + 
22 89 6.7 + + + + 
23 89 6.4 + + + + 
24 90 6.2 + + + + 
25 87 6.2 + + + + 
26 75 5.9 + + + + 
27 71. 6.8 + + + + 
28 66 6.1 + + + + 
29 63 6.0 + + - + 
30 62 5.9 + + + + 
31. 61. 5.9 + + - + 
32 59 5.8 + + + + 
33 66 9.0 + + - + 
34 63 9.0 + + - + 
35 62 >9.6 + + 
36 62 8.2 + + + + 
37 62 7.9 + + + + 
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Table 8. Continued 
Protein's Presence(+) 
orAbsence (-) in gels 
MW Apparent 
Spot# (kDa) PI. ll ll ll li 
38 61 7.4 + + + + 
39 61 7.1 + + + + 
40 58 6.8 + + + + 
41 43 8.6 + + + + 
42 44 7.7 + - + + 
43 48 7.1 + + + + 
44 46 6.9 + + 
45 33 9.0 + + + + 
46 32 8.6 + + 
47 31 7.2 + + 
48 <31 6.3 + + + + 
A 44 7.9 
- + 
B 45 7.7 
-
+ 
C 41 8,7 - + + 
D 35 >9.6 - + - + 
E 32 7.9 
- + 
F 87 >9.6 -
-
+ 
G 77 9.3 - - + 
H 75 9.3 
- - + 
I 62 9.3 
- - + 
J 60 9.3 
- -
+ 
K 73 7.9 
- - + 
L 71 8.1 -
-
+ 
M 39 >9.6 
- -
+ 
N 41 <4.65 
- - + 
0 <31 <4.65 
- - + 
p 88 7.6 - - + 
Q 87 7.5 
- - + 
R 89 7.4 
- - + Nl 59 <4.65 
- - - + 
o1 50 <4.65 - - - + 
IV. Proteins c, F - Q, and R were present in Treatment 
Group IV, but absent in Treatment Group II. 
Treatment Group V, supplemented with tamoxifen and 
17-~-estradiol, produced a polypeptide map identifying 38 
proteins (Figure 16). Proteins 1, 15, 17 - 20, 35, 44, 
46 and 47 were absent in Treatment Group V. Proteins D, 
N1 , and o1 were present in Treatment Group V, but absent 
in Treatment Group II. Data for 2-D gel electrophoresis 
on a-cell PIEs are presented in Tables. 
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CHAPTER IV 
DISCUSSION 
The application of molecular techniques, such as 
electrophoresis, to analyze mammalian embryos has allowed 
a better understanding of control mechanisms for early 
embryogenesis. Using data reported by numerous 
researchers, Schultz (1986), concluded that proteins 
synthesized from fertilization into the 2-cell embryo 
were the result of utilizing maternally-derived mRNA's. 
Schultz contended that the transition from maternal to 
embryonic genomic control begins in the 2-cell stage. 
This transition is probably both genetic and 
environmentally influenced. studies by Bowman & McLaren 
(1970a and b) and Spielmann, et al., (1980), have shown 
that PIEs cultured in vitro lag developmentally behind 
embryos maintained in vivo. This lag may be attributable 
to the absence of developmental factors within the 
maternal reproductive tract or to a reduction in some 
endogenous factor. steroids have been suggested to play 
a role in influencing RNA production, protein synthesis, 
and subsequent development. The influence of an 
estrogen, 17-~-estradiol, on PIE viability and protein 
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profiles at the 2-cell, 4-cell and a-cell stages of 
embryogenesis is reported in this research. 
Viability Considerations 
Viability studies for 2-cell, 4-cell and a-cell PIEs 
demonstrated Whitten's Modified Medium to be efficient 
for in vitro culturing of mouse embryos. Control groups 
for all embryonic stages successfully advanced to the 
next embryonic stage during the 8 hour incubation period. 
This was particularly significant for the 2-cell 
treatment groups because of the reported 2-cell block 
phenomenon for some mouse strains (Whitten and Biggers, 
1968). The addition of EDTA, as reported by Abramczuk, 
et al. (1977), allowed successful advancement of 2-cell 
PIEs, demonstrating the versatility of Whitten's Medium 
supplemented with EDTA. 
Culture experiments for 2-cell PIEs in the five 
treatment groups were completed and the resultant data 
are reported in Table 3. Data reported in Table 3 show 
that PIEs in the experimental control, Treatment Group 
II, were not significantly inhibited in their development 
by the presence of ethanol in the medium. Because 
·Treatment Groups II and III resulted in similar PIE 
viabilities, ethanol influence was considered unimportant 
as an experimental variable. 
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Estrogen treated 2-cell PIEs were inhibited in their 
advancement suggesting a toxic response to 17-~-
estradiol. In Treatment Group I, PIE advancement was 
significantly lower (p<0.05) than was the advancement 
obtained for all other treatment groups. These data 
suggest that 17-~-estradiol was not required for 2-cell 
PIE advancement, supporting-the genomic initiation theory 
as proposed by Schultz (1986). This theory states that 
early embryogensis through the 2-cell stage was regulated 
by macromolecules accumulated during oocyte maturation. 
According to Schultz, expression of the embryonic genome 
begins in late 2-cell PIEs. Once the embryonic genome 
has been activated, 17-~-estradiol stimulation should not 
be toxic for later stages of embryogensis. 
Tamoxifen treated 2-cell PIEs in Group IV progressed 
to the 4-cell stage similar to Group II demonstrating a 
lack of toxicity to embryo advancement. Twenty-five PIEs 
treated with tamoxifen and 17-~-estradiol in Group V 
advanced to the 4-cell stage, a significantly higher 
number than did PIEs treated with 17-~-estradiol in Group 
I (11 of 60). These data suggest that tamoxifen provided 
a shielding effect to the toxicity of 17-~-estradiol at 
the 2-cell stage. While the tamoxifen treatment in Group 
V provided some shielding from 17-~-estradiol the 
advancement percentage to the 4-cell stage remained 
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significantly less than that of the experimental control. 
Data generated for the 2-cell viability study show 17-~-
estradiol to be inhibitory to 2-cell PIE advancement. 
The results of the 4-cell and a-cell viability 
studies are reported in Tables 4 and 5, respectively. 
Comparison of data for 4-cell and a-cell cultured PIEs 
show similar advancement percentages within treatment 
groups. 
PIEs in Treatment Groups II (ethanol-saline) and III 
' ' 
(medium control) advanced to the next embryonic stage in 
both the 4-cell and a-cell studies at percentage rates 
similar to those reported in Table 3 for 2-cell PIEs. 
These data for the control groups suggest consistency in 
experimental design. and the application of laboratory 
techniques. 
Data reported in Tables 4 and 5 for 4-cell and 
a-cell PIEs treated with 17-~-estradiol (Group I), show 
that advancement percentages occurred at the same rate as 
did those obtained for the experimental controls, unlike 
the 17-~-estradiol treatment in 2-cell PIEs which were 
significantly less than experimental controls. The 
addition of 17-~-estradiol to 4-cell and a-cell PIEs did 
not enhance progression, but the toxic effects of 
estrogen, as demonstrated in the 2-cell study, were not 
observed. These data for 4-cell and a-cell PIEs support 
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the conclusion of Warner and Tollefson (1977), that 
exogenously administered physiological concentrations of 
17-$-estradiol would neither inhibit nor enhance embryo 
advancement. 
Tamoxifen treated (Group IV) 4-cell and a-cell PIEs 
advanced to the next embryonic stage at a significantly 
lower levels (p<0.05) than did the controls and 17-e-
estradiol treated groups. Because tamoxifen treated 
2-cell PIEs advanced to the 4-cell stage similar to the 
experimental control, tamoxifen toxicity at the 4-cell 
and a-cell PIE stages would not be expected. Sengupta, 
et al. (1977, 1982 and 1983), working with mouse morulas 
and blastocysts, suggested that PIEs were capable of 
endogenous estrogen production. Dey and Dickmann (1974) 
demonstrated the presence of steroidogenic enzymes in 
late 2-cell PIEs. Schultz (1986) stated that the 
initiation of the embryonic genome occurred in late 2-
cell PIEs. These reports suggest that the embryonic 
genome, activated in late 2-cell PIEs, initiated the 
production of endogenous estrogen. Data for Treatment 
Group IV, found in Tables 4 and 5, show tamoxifen to have 
a negative effect on the advancement of 4-cell and a-cell 
PIEs. The negative influence of tamoxifen on 4-cell and 
a-cell PIEs indicates the blockage of endogenously 
produced estrogen. 
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Data reported for Treatment Group V, tamoxifen plus 
17-e-estradiol, for 4-cell and 8-cell PIEs (Tables 4 and 
5) show significance (p<0.05) when compared to 
experimental controls. Results for the tamoxifen study 
in Group IV, and the tamoxifen plus 17-e-estradiol in 
Group V were similar. These data further support 
tamoxifen's ability to block endogenously produced 
estrogen. Additionally, data suggest the advancement of 
4-cell and 8-cell PIEs to be estrogen dependent and that 
the addition of lµg of 17-e-estradiol to be insufficient 
to overcome the antiestogenic properties of tamoxifen. 
Sengupta, et al. (1982), reported that administration of 
17-e-estradiol reversed the inhibitory effects of 
nafoxidine in mouse blastocysts. The results obtained 
for Group V suggest that tamoxifen may have greater 
antiestrogenic properties than those of nafoxidine. This 
conclusion is based on 17-e-estradiol's inability to 
reverse the inhibitory effects of tamoxifen in 4-cell and 
8-cell cultured PIEs during the viability study. 
Electrophoretic Considerations 
Protein profiles for 2-cell PIEs were constructed 
following 2-D polyacrylamide gel electrophoresis for each 
treatment group. The results of the mapped proteins-are 
tabulated in Table 6. Mapped proteins for the treatment 
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groups for 2-cell PIEs were similar. Proteins 1 - 46 
occurred on all gels with two exceptions. Protein 15 was 
absent on the 17-~-estradiol map amd protein 44 was 
absent on the tamoxifen plus 17-~-estradiol map. The 
absence of both proteins resulted from resolution 
problems among the gels. The absence of proteins 47 - 50 
in t~e 17-~- estradiol treatment group suggest these 
proteins were synthesized in the late 2-cell or early 4-
cell stage. Because the 17-~-estradiol group did not 
advance to the 4-cell stage, proteins 47 - 50 were not 
synthesized. Similarly, proteins 47 - 50 were absent in 
the tamoxifen treated group, which'advanced to the 4-cell 
·stage. This suggests proteins 47 - 50 to be dependent 
on endogenous estrogen and these proteins were blocked by 
tamoxifen. In the tamoxifen plus 17-~-estradiol group, 
proteins 47, 49 and 50 were absent as a result of 
tamoxifen blockage. The reappearance of protein 48 
probably resulted from genomic reactivition influenced by 
17-~-estradiol. 
Protein 52, absent in tamoxifen treated PIEs, 
apparently was estrogen dependent and synthezied at the 
time of embryonic genome initiation. Absence of proteins 
57, A, B, c, D, and G resulted from resolution problems 
and the interpretation of polypeptide maps within the 
2-cell treatment groups. The appearance of protein Eon 
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the 17-~-estradiol map was art unexplained phenomenon. 
Protein F appears to be tamoxifen dependent because it 
occured only in the tamoxifen treated group. Available 
literature for tamoxifen suggests a lack of transcription 
initiation, eliminating direct genomic influence on 
protein synthesis (Jordan and Murphy, 1990). Therefore, 
protein Fis believed to be an artifact. The occurrence 
of protein H·in the tamoxifen plus 17-~-estradiol group 
would be predictable if this protein was present in the 
experimental control. Examination of the experimental 
control map indicates that protein 43 probably includes 
protein H. The perceived absence of protein Hin the 
experimental control was a result of resolution. Like 
protein 48, protein H was estrogen dependent. 
overall, the protein maps for the treatment groups 
in the 2-cell study were similar. Most of the proteins 
were present on all maps or they were accounted for 
through interpretation of the 2-D gels. Because 
embryonic genome activation does not occur until the late 
2-cell stage, proteins present on the 2-cell maps were 
either maternally derived proteins or they were proteins 
synthesized from maternally derived mRNA. Predictably, 
the 2-cell polypeptide maps should be similar because of 
this maternal derivation. This conclusion was supported 
by the 2-cell viability data (Table 3), which clearly 
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shows that embryonic genome activation does not occur 
until the late 2-cell stage. Further, 2-cell PIE 
advancement is not estrogen dependent. 
Protein profiles constructed for the treatment 
groups in the 4-cell PIE study demonstrate estrogen 
dependency for progressive development. Data from the 
polypeptide maps reported in Table 7 show the 
experimental control and 17-e-estradiol treated groups to 
be similar, while the tamoxifen and tamoxifen plus 17-e-
estradiol groups were similar. Of the 71 proteins 
identified in the experimental control, 68 were found in 
the 17-e-estradiol treated 4-cell PIEs. Proteins 2 and 3 
were absent in the 17-e-estradiol group as the result of 
an unexplained resolution problem. The absence of 
protein 53 from the 17-e-estradiol group and the 
tamoxifen plus 17-e-estradiol group suggests this protein 
was estrogen sensitive. Presence of protein A in the 
17-e-estradiol group may be a result of estrogen 
stimulation at the 8-cell stage. 
In comparing the tamoxifen and tamoxifen plus 17-e-
estradiol groups to the experimental control, 27 proteins 
present in the control were absent in both tamoxifen 
treated groups. Proteins absent in tamoxifen cultured 
4-cell PIEs were 11 - 15, 17, 18, 21, 23, 24, 27, 31, 32, 
35, 36, 41, 49, 56, 61, 62, 64 - 66, and 68 - 71. These 
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proteins were clearly estrogen dependent and their 
production was inhibited by the presence of tamoxifen. 
The reported absence of protein 51 in the 4-cell 
tamoxifen plus 17-~-estradiol group can not be explained 
at this time. Results from other treatments, namely 
Groups I and IV, show spot 51 as being distinct on 
protein maps where supplements of tamoxifen or 17-~-
estradiol were adminstered. Evidence suggests that 
protein 51 should have been present on all gels. An 
explanation for the presence of proteins Band C in 
tamoxifen treated groups may be due to the lack of embryo 
progression in the 4-cell PIEs for both groups. Data 
suggest that proteins Band C were not carried into the 
8-cell stage because of their absence in the experimental 
control and 17-~-estradiol groups. 
Viability data, reported in Table 4 show that the 
experimental group (Group II) and the 17-~-estradiol 
group (Group I) differ significantly from the tamoxifen 
(Group IV) and tamoxifen plus 17-~-estradiol group (Group 
V) with respect to 4-cell PIE advancement to the 8-cell 
stage. Data reported for protein profiles for 4-cell 
treated PIEs presented in Table 7 support the viability 
data. It can be concluded from these data that 4-cell 
progression was estrogen dependent and that tamoxifen 
exhibited antiestrogenic properties. 
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The results of the a-cell 2-D gel study (Table 8) 
were similar to the 4-cell study when comparing the 
experimental control and 17-B-estradiol treatments. Of 
the 48 proteins present in the control, 45 were 
identified for the 17-B-estradiol group. The absence of 
protein 1 was most likely the result of a lack of 
resolution on the 2-D gels. Protein 20 appears in the 8-
cell experimental control as one of several proteins 
present in the 4-cell treated PIEs. The absence of this 
protein in 17-B-estradiol treated a-cell PIES may reflect 
the inactivation of protein 20. In the 17-B-estradiol 
treatment, protein 42 was reported as being absent. 
However, on the 17-B-estradiol map, the new proteins A 
and B were positioned at approximately the same location 
as was protein 42. This suggests that proteins A and B 
were identified as an interpretative error in reading 
protein 42 on the 2-D gel for Group I. Proteins C and D 
reported as present in the 17-B-estradiol treatment may 
be the result of resolution problems in mapping proteins 
41 and 45, respectively. The absence of protein Eon the 
experimental control was most likely the result a 
deformity within the 2-D gel. 
Tamoxifen treated a-cell PIEs lacked 13 of the 48 
proteins present in the experimental control. The 
absence of these proteins suggest an estrogen dependence 
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and these results were similar to those reported for 4-
cell treated PIEs. Estrogen dependent proteins absent in 
tamoxifen treated PIEs were 16 - 20, 29, 31, 33 - 35, 44, 
46, 47, and E. Proteins F ~Mand P - R, reported for 
tamoxifen treated 8-cell PIEs, were probably remnants 
from the 8-cell stage that were maintained in this 
treatment group due to the lack of advancement among 
tamoxifen treated 8-cell PIEs. Among tamoxifen plus 
17-e-estradiol, treated PIEs, the absence of proteins 
17 - 20, 35, 44, 46, 47 and E reflect estrogen dependent 
proteins blocked by·tamoxifen. The presence of proteins 
16, 29, 31, 33, and 34 in the tamoxifen plus 17-e-
estradiol treatment suggests a reversal in the effects of 
tamoxifen in the presence of 17-e-estradiol. This is 
consistent with the findings of Sengupta, et al. (1982), 
for the reversal of nafoxidine by 17-e-estradiol mouse 
blastocyst. 
The protein maps for tamoxifen and tamoxifen plus 
17-e-estradiol for 8-cell PIEs generated 2 proteins on 
each gel that cannot be explained at this time. Proteins 
N and O on the tamoxifen map and N1 and o1 on the 
tamoxifen plus 17-e-estradiol map were unique to those 
gels. Because these spots were located at the extreme 
positive end of the tube gel, their identification as PIE 
proteins was suspect. 
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Overall, protein profiles for the a-cell treated 
PIEs were similar to those generated for 4-cell treated 
PIEs. The experimental group and the 17-~-estradiol 
group were similar in their protein profiles. Tamoxifen 
treated 8-cell PIEs, were inhibited in their development 
-by a demonstrated blockage of estrogen dependent 
proteins .• The presence of additional proteins on the 
tamoxifen map were proteins present at the time of 
incubation. The protein map for the tamoxifen plus 17-~-
estradiol treatment supports the results obtained from 
the tamoxifen group. Most of the proteins inhibited by 
tamoxifen in Treatment Group IV were similarly inhibited 
in Treatment Group V. Data from Group V suggest that 
the presence of 17-~-estradiol had a reversal influence 
on selected tamoxifen inhibited proteins. Further, the 
data from Treatment Groups IV and V suggest estrogen 
dependency for protein production when compared to Groups 
I and II. These conclusions are consistent with the 
results of the viability data for a-cell PIE advancement 
and suggest the presence of endogenous estrogen 
production by 8-cell PIEs. 
Summary 
Resultant data from the viability and electro-
phoretic studies were consistent within treatment groups 
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) 
for 2-cell, 4-cell and 8-cell PIEs. Culture experiments 
produced viable 2-cell PIEs at a significantly higher 
rate in the experimental control and tamoxifen 
supplemented group than did treatment groups receiving 
17-~-estradiol. Among 4-cell and 8-cell cultured PIEs, 
the ~xperimental control and the 17-~-estradiol treatment 
groups yielded significantly higher percentages of viable 
PIEs than did tamoxifen supplemented groups. These data 
support the concept of embryonic genome initation at the 
late 2-cell PIE stage as proposed by Schultz (1986). 
The apparent toxicity of 17-~-estradiol on 2-cell 
PIEs clearly demonstrates that the second cleavage 
division lacks estrogen dependence. Proteins identified 
on 2-cell, 2-D gels for all treatment groups were 
generally consistent. These protein profiles illustrate 
the dependence of early embryogenesis on maternally-
derived macromolecules (Chen, et al., 1980; Van Blerkom, 
1981a and 1985; Van Blerkom and Runner, 1989; Magnuson 
and Epstein, 1987). 
Viability studies for 4-cell and 8-cell PIEs 
produced similar results for specific PIE treatments. 
Tamoxifen treated groups yielded significantly fewer 
advancing PIEs as compared to the 17-~-estradiol 
treatment. These results support the non-steroidal 
antiestrogenic properties reported for other 
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antiestrogens such as nafoxidine and CI-628 (Clark, et 
al., 1973 and 1974; Ferguson and Katzenellenbogen, 1977; 
Katzenellenbogen, et al., 1979). Further, the 
significant reduction in PIE advancement within the 
tamoxifen treated group, as compared to the experimental 
control, demonstrates the suggested production of 
endogenous estrogen by PIEs (Dey and Dickmann, 1974; 
Dickmann, et al., 1976). 
Protein profiles produced for tamoxifen treated 
4-cell and a-cell PIEs show a reduction in protein 
content as compared to 17-~-estradiol treated PIEs. 
Because tamoxifen treated PIEs failed to advance to the 
morula stage, this reduction in protein synthesis 
suggests that 4-cell and 8-cell PIE advancement is 
estrogen dependent. Therefore, the similarity between 
the experimental control and the 17-~-estradiol treatment 
group, in both viability and 2-D gel studies, would 
suggest the occurrence of endogenous estrogen. Warner 
and Tollefson (1977), reported that exogenous supplements 
of physiological concentrations of 17-~-estradiol would 
not enhance PIE viability. Data produced in both 
viability and electrophoretic studies confirm this 
conclusion, however, electrophoretic data show that 
exogenous estrogen does not stimulate protein production. 
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Comparision of the tamoxifen plus 17-~-estradiol 
4-cell and a-cell treatments to those of the 17-~-
estradiol treatment show significant reduction in PIE 
advancement. Within the 4-cell treatments, viability and 
electrophoretic data suggest that estrogen blockage is 
complete. In viability studies with a-cell PIEs Roy, et 
al. (1981), Reported that lµg of 17-~-estradiol would not 
reverse the effects of 3µg of nafoxidine. Data produced 
for'tamoxifen plus 17-~-estradiol treated PIEs show 
similar results for PIE viability, but, electrophoretic 
data suggest that some protein reversal had occurred. 
These protein reversals were not significant enough to 
reverse PIE viability at the a-cell stage. Sengupta, et 
al. (1977, 1982 and 1983), reported viability reversal 
for nafoxidine treated mouse morulas and blastocysts when 
exogenous 17-~-estradiol was added to nafoxidine 
supplemented culture medium. While the tamoxifen plus 
17-~-estradiol viability and electrophoretic data for 8-
cell PIEs does not support the conclusions of Sengupta, 
et al., the difference is probably due to the stage of 
embryogeneis. 
Overall, data generated: (1) support the concept 
of embryonic genome initation at the late 2-cell stage, 
(2) show that enhancement of protein synthesis will not 
result from exogenous supplements of 17-~-estradiol in 
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2-cell, 4-cell, and 8-cell PIEs, and (3) demonstrate 
that_tamoxifen exerts antiestrogenic properties resulting 
in decreased protein synthesis and PIE viability. In 
addition, data suggest that 4-cell and 8-cell PIEs are 
estrogen dependent and that endogenous estrogen 
production influences 4-cell and a-cell PIE 
embryogenesis. 
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CHAPTER V 
CONCLUSIONS 
Data generated through viability and 2-D gel 
electrophoresis studies clearly show that exogenously 
administered 17-0-estradiol supplements to Whitten's 
Modified Medium does not enhance protein synthesis in 
2-cell, 4-cell, and a-cell preimplantation embryos. 
Administration of 11-0-estradiol was toxic to 2-cell PIEs 
but among 4-cell and a-cell cultured PIEs, 11-0-estradiol 
data were equal to that of control treatments. In 4-cell 
and a-cell PIE electrophoretic studies, protein profiles 
were neither enhanced nor inhibited by 17-0-estradiol. 
Therefore, the null hypothesis is accepted; that 17-0-
estradiol was without effect on PIE protein profiles. 
Tamoxifen treated 2-cell PIEs produced results 
similar to those of the experimental control, suggesting 
a lack of estrogen influence on 2-cell PIE advancement. 
Within 4-cell and a-cell treatments, data show estrogen 
dependence for PIE advancement. Tamoxifen treated PIE 
cultures in both viability and electrophoretic studies 
were blocked or inhibited in their development. These 
data demonstate the antiestrogenic properties of 
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tamoxifen on 4-cell and a-cell PIEs. Therefore, the 
hypothesis that tamoxifen inhibits 17-~-estradiol in 
mouse PIEs is accepted. 
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